Jul 28, 2021 (IAM Newswire via COMTEX) -- Last week's 19 IPO week had a lot of life sciences and software. This week, US IPO activity continues at a record with 25 scheduled IPOs, marking the fifth week in 2021 with at least 17 US IPOs, the most since 2000. With the August lull just around the corner, five SPACs raised $895.
Here is a little recap as we prepare for another record week.
Protein therapy platform Absci Corp /zigman2/quotes/228095887/composite ABSI -6.63% raised $200 million at a $1.6 billion market cap, finishing up 43%. It has nine active programs across seven partners, which include Merck &Co /zigman2/quotes/209956077/composite MRK -0.74% and Astellas Pharma Inc /zigman2/quotes/205728169/composite ALPMY -0.26% , for which it has either negotiated or plans to negotiate license agreements. Itt remains highly unprofitable with 90% of its tech development revenue coming from a single partner in the first quarter of the year.
Couchbase /zigman2/quotes/228069022/composite BASE -7.78% finished up 42%, raising $200 million at a $1.2 billion market cap. Although unprofitable due to high S&M costs, it has a sticky customer base for which it provides a NoSQL database that enterprises and developers can use to build and run applications across various environments.
Legal software provider CS Disco /zigman2/quotes/228068816/composite LAW -2.22% rose $224 million at a $1.9 billion market cap, finishing up 40%. Fast growing and unprofitable, it provides a cloud-native, AI-powered platform that simplifies the legal case management. Although near term rise in expenses is expected with a post-COVID environment, margins have improved.
A company providing a B2C e-commerce platform that combines commerce, order management, and marketplace functionality to enterprises, Latin America's VTEX /zigman2/quotes/228075416/composite VTEX -4.13% raised $361 million at a $3.8 billion market cap and finished up 34%. Despite its R&D investments weighting on profits, this is a positive growth story.
Though highly leveraged post its IPO, Ryan Specialty Group Holdings /zigman2/quotes/228069582/composite RYAN -0.71% raised $1.3 billion at a $6.1 billion market cap. Risk is part of its DNA as this company assists retail brokers place and manage hard-to-place risks, demonstrating strong organic growth along the way.
Profitable with steadily improving margins water infrastructure company Core & Main Inc /zigman2/quotes/227698862/composite CNM +0.04% rose $698 million at a $4.8 billion market cap. Its infrastructure connects 4,500 suppliers to over 60,000 customers.
Provider of live and on demand video products, Kaltura Inc /zigman2/quotes/225665451/composite KLTR -6.67% , raised $150 million at a $1.4 billion market cap, finishing up 18%. As the world is increasingly adopting digital events, the company's revenue expanded during the first quarter of the year, but the gross margin contracted.
HR software provider Paycor HCM Inc /zigman2/quotes/227704077/composite PYCR -1.66% rose $426 million at a $4.0 billion market cap, finishing up 17%. Although net revenue retention fell last fiscal year, the company has a track record of profitability and is targeting a larger audience.
Profitable with explosive growth cell analysis instruments provider Cytek BioSciences /zigman2/quotes/228313453/composite CTKB -2.57% raised $285 million at a $2.3 billion market cap, finishing up 10%. It provided over 750 instruments to over 620 companies around the world by the end of March.
Miami community bank owning 11 banking centers and a digital banking platform, U.S. Century Bank /zigman2/quotes/228268216/composite USCB -0.32% , raised $40 million at a $183 million market cap, finishing up 8%. Total assets amounted to $1.6 billion as of March 31 [st] .
Largest boutique fitness franchisor in the US with over 1,750 studios operating across nine distinct brands, Xponential Fitness /zigman2/quotes/228267660/composite XPOF +0.20% , raised $120 million at a $529 million market cap. Q2 results show it has rebounded from the pandemic 60% revenue growth and adjusted EBITDA swinging positive
Gene editing biotech Caribou Biosciences (nasdq:CRBU) raised $304 million at a $972 million market cap. It is developing genome-edited allogenic cell therapies, with its main product in Phase 1, targeting relapsed or refractory B cell non-Hodgkin lymphoma.
The LMS market leader in higher education and paid K-12, with over 6,000 global customers across 90 countries, Instructure Holdings Inc /zigman2/quotes/200628597/composite INST -5.27% , raised $250 million at a $2.9 billion market cap. Profitable on an EBIT basis with solid growth, but with a contracting gross margin over the last two fiscal years and latest quarter.
Content marketing platform that helps engage users and monetize visits by gathering over 1 billion data events each minute, Outbrain Inc /zigman2/quotes/228095876/composite OB +0.56% , raised $160 million at a $1.2 billion market cap, finishing flat. Although profitable and growing, it does not have long-term commitments from advertisers.
Performance marketing company and a digital marketing services provider Gambling.com Group (nadsaq:GAMB) raised $42 million at a $288 million market cap, finishing flat. It focuses on iGaming and sports betting.
Beverage brand Zevia PBC /zigman2/quotes/228083382/composite ZVIA -3.95% raised $150 million at a $986 million market cap, finishing 2% down. It is consistently growing and steadily expanding its retail footprint in an increasingly crowded market of the US and Canada.
Swiss health tech company that provides a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets, SOPHiA GENETICS /zigman2/quotes/228313448/composite SOPH -1.15% , raised $234 million at a $1.2 billion market cap.
Brazil's Zenvia Inc /zigman2/quotes/226582177/composite ZENV -0.58% , whose software platform facilitates the flow of communication, raised $150 million at a $508 million market cap, finishing down 22%. It served more than 10,190 customers in Latin America as of March 31 [st] , achieving a net revenue expansion of nearly 110%, but EBITDA turned negative in the first quarter.
Immunotherapy biotech HCW Biologics Inc /zigman2/quotes/227704113/composite HCWB -6.07% raised $56 million at a $290 million market cap, finishing down 35%. Its molecule is currently being evaluated in two ongoing Phase 2 trials for relapsed/refractory acute myeloid leukemia with preliminary results expected in the second half of the year.
This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: Contributors – IAM Newswire accepts pitches. If you're interested in becoming an IAM journalist contact:
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.